Search for: [Abstract = "Radioiodine therapy is commonly considered to be safe and efficacious treatment option for hyperthyroidism in the course of Graves’ disease. Despite the fact that radioiodine treatment has been used since 1940s, an explicit algorithm regarding radioiodine activity selection has not yet been established. There are two methods of radioiodine activity selection currently used in the clinical practice\: one is calculated doses regimen based on formula taking into account glandular volume and estimated radioiodine uptakewhile the other one relies on the use of fixed doses.The aim of this study was to assess radioiodine therapy efficacy in patients with Graves' disease and to analyze factors that influence the effectiveness of the treatment.362 patients with Graves' disease \(80,9% female, 19,1% male\) treated in the years 2006\-2010 in the Nuclear Medicine Center, Division of Clinical Endocrinology Ward at the Jagiellonian University in Cracow were enrolled in the study. Hyperthyroidism in the course of Graves’ disease was diagnosed based on clinical picture, pathology results, thyroid ultrasound and thyroid scintigraphy results. Age median of the studied group of the patients was 53 years \(min 14 to 85 max\). Thyroid volume in men \(30 mls \[18.95\-52,75\]\) proved to be statistically bigger than in women \(24 ml \[16.1\- 37\]\) \(p=0,006\). Thyroid nodules were found in 164 patients \(84% women and"]

Number of results: 1